Jeffrey Teckman

6.6k total citations
113 papers, 4.3k citations indexed

About

Jeffrey Teckman is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jeffrey Teckman has authored 113 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 44 papers in Cancer Research and 38 papers in Oncology. Recurrent topics in Jeffrey Teckman's work include Protease and Inhibitor Mechanisms (41 papers), Peptidase Inhibition and Analysis (31 papers) and Endoplasmic Reticulum Stress and Disease (27 papers). Jeffrey Teckman is often cited by papers focused on Protease and Inhibitor Mechanisms (41 papers), Peptidase Inhibition and Analysis (31 papers) and Endoplasmic Reticulum Stress and Disease (27 papers). Jeffrey Teckman collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey Teckman's co-authors include David H. Perlmutter, Keith Blomenkamp, Dongfeng Qu, Satoshi Ōmura, Béla Z. Schmidt, Dhiren Patel, David A. Lomas, Douglas Lindblad, Mark Brantly and James K. Stoller and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jeffrey Teckman

110 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Teckman United States 38 1.7k 1.4k 1.2k 1.2k 1.1k 113 4.3k
David H. Perlmutter United States 30 1.4k 0.8× 694 0.5× 1.0k 0.8× 1.2k 1.0× 647 0.6× 54 3.8k
Kasper M.A. Rouschop Netherlands 32 1.9k 1.2× 918 0.7× 862 0.7× 1.5k 1.3× 373 0.3× 67 4.1k
Julia I-Ju Leu United States 23 2.6k 1.6× 867 0.6× 377 0.3× 458 0.4× 1.6k 1.5× 36 3.8k
Zsuzsa Schaff Hungary 34 1.1k 0.7× 604 0.4× 513 0.4× 805 0.7× 619 0.6× 154 3.4k
Elaine M. Hurt United States 35 3.1k 1.9× 1.0k 0.8× 654 0.5× 410 0.3× 2.4k 2.3× 59 6.3k
Wei Tong United States 34 2.7k 1.6× 576 0.4× 254 0.2× 382 0.3× 948 0.9× 84 5.6k
Alice Mui Canada 40 2.6k 1.6× 747 0.5× 227 0.2× 424 0.4× 2.6k 2.4× 92 6.5k
Keisuke Tateishi Japan 41 3.4k 2.0× 869 0.6× 234 0.2× 585 0.5× 2.1k 2.0× 136 5.7k
Véronique Barbu France 35 1.5k 0.9× 443 0.3× 154 0.1× 963 0.8× 1.1k 1.1× 85 4.1k
Zhiyong Guo China 39 2.3k 1.4× 1.1k 0.8× 180 0.1× 665 0.6× 818 0.8× 126 5.6k

Countries citing papers authored by Jeffrey Teckman

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Teckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Teckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Teckman more than expected).

Fields of papers citing papers by Jeffrey Teckman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Teckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Teckman. The network helps show where Jeffrey Teckman may publish in the future.

Co-authorship network of co-authors of Jeffrey Teckman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Teckman. A scholar is included among the top collaborators of Jeffrey Teckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Teckman. Jeffrey Teckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loomba, Rohit, Jeffrey Teckman, Veeral Ajmera, et al.. (2024). Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease. Alimentary Pharmacology & Therapeutics. 59(10). 1183–1195. 3 indexed citations
2.
Zhang, Zidong, Brent A. Neuschwander‐Tetri, Rohit Loomba, et al.. (2023). Sa1546 INCREASED LIVER FIBROSIS IS THE KEY CLINICAL FACTOR ASSOCIATED WITH INCREASED FUTURE SEVERE LIVER DISEASE OUTCOMES IN A PROSPECTIVE COHORT OF ADULTS WITH ALPHA-1-ANTITRYPSIN DEFICIENCY. Gastroenterology. 164(6). S–1286. 1 indexed citations
3.
Strnad, Pavel, Mattias Mandorfer, Gourab Choudhury, et al.. (2022). Fazirsiran for Liver Disease Associated with Alpha 1 -Antitrypsin Deficiency. New England Journal of Medicine. 387(6). 514–524. 65 indexed citations
4.
Teckman, Jeffrey, et al.. (2021). Review of Gastrointestinal Motility in Cystic Fibrosis. Journal of Cystic Fibrosis. 20(4). 578–585. 24 indexed citations
5.
Patel, Dhiren, et al.. (2020). Alpha-1 antitrypsin deficiency liver disease. Translational Gastroenterology and Hepatology. 6. 23–23. 29 indexed citations
6.
Wooddell, Christine I., Keith Blomenkamp, Ryan M. Peterson, et al.. (2020). Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease. JCI Insight. 5(12). 40 indexed citations
7.
Teckman, Jeffrey, et al.. (2018). Eating Disorders are Prominent Among the Comorbidities of Eosinophilic Esophagitis in a U.S. Midwestern Children’s Hospital. Journal of Allergy and Clinical Immunology. 141(2). AB144–AB144. 1 indexed citations
8.
Rosenthal, Philip, Simon C. Ling, Steven H. Belle, et al.. (2018). Combination of Entecavir/Peginterferon Alfa‐2a in Children With Hepatitis B e Antigen–Positive Immune Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 69(6). 2326–2337. 41 indexed citations
9.
Tang, Youcai, Keith Blomenkamp, Peter Fickert, Michael Trauner, & Jeffrey Teckman. (2018). NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway. PLoS ONE. 13(8). e0200897–e0200897. 27 indexed citations
10.
Teckman, Jeffrey & Keith Blomenkamp. (2017). Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease. Methods in molecular biology. 1639. 1–8. 24 indexed citations
11.
Sandhaus, Robert A., Gerard Turino, Mark Brantly, et al.. (2016). The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 3(3). 668–682. 140 indexed citations
12.
Greene, Catherine M., Stefan J. Marciniak, Jeffrey Teckman, et al.. (2016). α1-Antitrypsin deficiency. Nature Reviews Disease Primers. 2(1). 16051–16051. 228 indexed citations
13.
Kamath, Binita M., Zhen Chen, René Romero, et al.. (2015). Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome. The Journal of Pediatrics. 167(2). 390–396.e3. 18 indexed citations
14.
Teckman, Jeffrey & Nisha Mangalat. (2014). Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions. Expert Review of Gastroenterology & Hepatology. 9(2). 261–268. 35 indexed citations
15.
Nelson, David R., Jeffrey Teckman, Adrian M. Di Bisceglie, & David A. Brenner. (2011). Diagnosis and Management of Patients With α1-Antitrypsin (A1AT) Deficiency. Clinical Gastroenterology and Hepatology. 10(6). 575–580. 62 indexed citations
16.
Cruz, Pedro E., Christian Mueller, Travis Cossette, et al.. (2007). In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA. Laboratory Investigation. 87(9). 893–902. 44 indexed citations
17.
Blomenkamp, Keith, et al.. (2005). Quantitative isolation of α1AT mutant Z protein polymers from human and mouse livers and the effect of heat. Hepatology. 41(1). 160–167. 46 indexed citations
18.
Teckman, Jeffrey. (2004). Lack of Effect of Oral 4‐Phenylbutyrate on Serum Alpha‐1‐Antitrypsin in Patients with α‐1‐Antitrypsin Deficiency: A Preliminary Study. Journal of Pediatric Gastroenterology and Nutrition. 39(1). 34–37. 1 indexed citations
19.
Rudnick, David A., et al.. (2004). Analyses of hepatocellular proliferation in a mouse model of α-1-antitrypsin deficiency. Hepatology. 39(4). 1048–1055. 98 indexed citations
20.
Teckman, Jeffrey & David H. Perlmutter. (1996). The Endoplasmic Reticulum Degradation Pathway for Mutant Secretory Proteins α1-Antitrypsin Z and S Is Distinct from That for an Unassembled Membrane Protein. Journal of Biological Chemistry. 271(22). 13215–13220. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Perlmutter Breakdown of academic impact, for papers by Kasper M.A. Rouschop Breakdown of academic impact, for papers by Julia I-Ju Leu Breakdown of academic impact, for papers by Zsuzsa Schaff Breakdown of academic impact, for papers by Elaine M. Hurt Breakdown of academic impact, for papers by Wei Tong Breakdown of academic impact, for papers by Alice Mui Breakdown of academic impact, for papers by Keisuke Tateishi Breakdown of academic impact, for papers by Véronique Barbu Breakdown of academic impact, for papers by Zhiyong Guo
Rankless by CCL
2026